Murphy2016_Article_FAKAndPyk2InDisease.pdf (386.33 kB)
Download fileMurphy2016_Article_FAKAndPyk2InDisease.pdf
journal contribution
posted on 2019-03-04, 21:28 authored by james murphy, Hyeonsoo Park, Ssang-Taek LimFocal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2) are non-receptor protein tyrosine
kinases that are involved in cell proliferation, migration and survival. Current research of FAK and Pyk2 is greatly
focused in cancer biology and several small molecule inhibitors are being tested under clinical development. Like cancer,
certain chronic diseases such as cardiovascular disease, bone disease, fibrosis, rheumatoid arthritis, and neurological
disorders, share malignant characteristics of cancer. Accumulating evidence has demonstrated that FAK and Pyk2
contribute to other proliferative and degenerative diseases. Thus, the goal of this review is to briefly highlight studies
that have implicated FAK and Pyk2 as players in disease progression.
kinases that are involved in cell proliferation, migration and survival. Current research of FAK and Pyk2 is greatly
focused in cancer biology and several small molecule inhibitors are being tested under clinical development. Like cancer,
certain chronic diseases such as cardiovascular disease, bone disease, fibrosis, rheumatoid arthritis, and neurological
disorders, share malignant characteristics of cancer. Accumulating evidence has demonstrated that FAK and Pyk2
contribute to other proliferative and degenerative diseases. Thus, the goal of this review is to briefly highlight studies
that have implicated FAK and Pyk2 as players in disease progression.
